MoonLake Immunotherapeutics

NASDAQ:MLTX

38.55 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Revenue 0.1020000.02000000000000
Cost of Revenue 0.05100.0280.0230.0030.0030.0030.00300.0030000000
Gross Profit 0.0510-0.028-0.0230.016-0.003-0.003-0.0030-0.0030000000
Gross Profit Ratio 0.50000.833000000000000
Reseach & Development Expenses 40.3635.73623.63412.9918.0957.5858.7047.41511.3699.02411.40110.45512.0980.6729.86700
General & Administrative Expenses 30,298.6817.3766.9166.8066.9315.3924.4825.5165.3275.7466.2525.48712.8945.5982.81500
Selling & Marketing Expenses -30,289.4600000000000-10.670000
SG&A 9.2217.3766.9166.8066.9315.3924.4825.5165.3275.7466.2525.4872.2245.5982.8150.0940.101
Other Expenses -11.85305.9375.9157.1861.3860.8430.72400.0380.2450.070.007-0.021-0.0040.0180
Operating Expenses 49.5843.11230.5519.79815.02612.97713.18612.93216.69614.77117.65215.9422.2246.26732.6820.0940.101
Operating Income -49.58-43.112-30.578-19.82-15.029-12.977-13.186-12.932-16.696-14.771-17.652-15.942-2.224-6.267-32.682-0.094-0.101
Operating Income Ratio -486.798000-761.419000000000000
Total Other Income Expenses Net 3.2267.095.8985.9157.1861.3860.8430.7240.240.0380.2450.07-22.817-0.021-0.0040.0180.015
Income Before Tax -46.355-36.022-24.68-13.905-7.843-11.59-12.343-12.208-16.457-14.733-17.407-15.873-2.222-6.288-32.686-0.076-0.086
Income Before Tax Ratio -455.126000-397.36000000000000
Income Tax Expense -282.440.0920.0790.070.0440.0290.010.0110.0110.0090.0090.0070.0060-0-0.0550
Net Income -45.605-35.39-24.267-13.674-7.437-9.426-10.139-12.219-1.935-14.742-17.416-15.88-2.222-6.288-32.686-0.076-0.086
Net Income Ratio -447.762000-376.79000000000000
EPS 1.16-0.56-0.39-0.22-0.12-0.18-0.23-0.31-0.05-0.4-0.49-0.43-0.15-0.17-0.89-0.005-0.006
EPS Diluted 1.16-0.56-0.39-0.22-0.12-0.18-0.23-0.31-0.05-0.4-0.49-0.43-0.15-0.17-0.89-0.005-0.006
EBITDA -48.279-43.079-30.55-19.798-15.026-12.973-13.183-12.928-16.693-14.767-17.649-15.94-2.224-6.265-32.6820-0.086
EBITDA Ratio -474.021000-761.252000000000000